Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giannoula Klement

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Dermatology Online Journal|June 22, 2017
Klippel-Trenauney syndrome with axillary hyperhidrosisYeun Jina Lim, David Rosmarin, Giannoula Klement, et al.
Cancer Research|March 26, 2002
Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenograftsJoanne L Yu, Janusz W Rak, Giannoula Klement, et al.
The American Journal of Pathology|November 8, 2008
Tumors stimulate platelet delivery of angiogenic factors in vivo: an unexpected benefitGiorgio Pietramaggiori, Saja S Scherer, David Cervi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Targeting cyclooxygenase-2 reduces overt toxicity toward low-dose vinblastine and extends survival of juvenile mice with Friend diseaseDave Cervi, Giannoula Klement, Diana Stempak, et al.
Medical and Pediatric Oncology|November 5, 2003
Differences in vasculature between pilocytic and anaplastic astrocytomas of childhoodBenjamin Gesundheit, Giannoula Klement, Christof Senger, et al.
Medical Physics|March 6, 2004
MicroCT scanner performance and considerations for vascular specimen imagingMichael Marxen, Michael M Thornton, Cameron B Chiarot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenograftsGiannoula Klement, Ping Huang, Barbara Mayer, et al.
Blood|February 11, 2005
The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cellsYuval Shaked, Dave Cervi, Manuela Neuman, et al.
Breast Cancer Research and Treatment|September 25, 2012
Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomicsErica L Mayer, Steven J Isakoff, Giannoula Klement, et al.
Journal of Pediatric Surgery|January 9, 2007
Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registryEmily R Christison-Lagay, Patricia E Burrows, Ahmad Alomari, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Dermatology Online Journal|June 22, 2017
Klippel-Trenauney syndrome with axillary hyperhidrosisYeun Jina Lim, David Rosmarin, Giannoula Klement, et al.
Cancer Research|March 26, 2002
Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenograftsJoanne L Yu, Janusz W Rak, Giannoula Klement, et al.
The American Journal of Pathology|November 8, 2008
Tumors stimulate platelet delivery of angiogenic factors in vivo: an unexpected benefitGiorgio Pietramaggiori, Saja S Scherer, David Cervi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Targeting cyclooxygenase-2 reduces overt toxicity toward low-dose vinblastine and extends survival of juvenile mice with Friend diseaseDave Cervi, Giannoula Klement, Diana Stempak, et al.
Medical and Pediatric Oncology|November 5, 2003
Differences in vasculature between pilocytic and anaplastic astrocytomas of childhoodBenjamin Gesundheit, Giannoula Klement, Christof Senger, et al.
Medical Physics|March 6, 2004
MicroCT scanner performance and considerations for vascular specimen imagingMichael Marxen, Michael M Thornton, Cameron B Chiarot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenograftsGiannoula Klement, Ping Huang, Barbara Mayer, et al.
Blood|February 11, 2005
The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cellsYuval Shaked, Dave Cervi, Manuela Neuman, et al.
Breast Cancer Research and Treatment|September 25, 2012
Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomicsErica L Mayer, Steven J Isakoff, Giannoula Klement, et al.
Journal of Pediatric Surgery|January 9, 2007
Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registryEmily R Christison-Lagay, Patricia E Burrows, Ahmad Alomari, et al.
Pageof 2